Exploiting T cell signaling to optimize engineered T cell therapies
-
Published:2022-02
Issue:2
Volume:8
Page:123-134
-
ISSN:2405-8033
-
Container-title:Trends in Cancer
-
language:en
-
Short-container-title:Trends in Cancer
Author:
Wang Haopeng,
Song Xianming,
Shen Lianjun,
Wang Xinxin,
Xu ChenqiORCID
Subject
Cancer Research,Oncology
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献